Troy Cox
CIK 1696923 · Executive Chair · last filed 2026-06-25
Troy Cox is an Executive Chair who has filed 29 SEC Form 4 insider transactions across 6 companies since 2017. The most recent filing, for MPLT, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.52M
6
29
-$2.98M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MPLT | Director | 7,864 | $15.12 | $118.9K | $0 | 1 | 2026-06-25 |
| LAB | Director | 475,702 | $0.87 | $415.7K | $0 | 7 | 2026-06-23 |
| SOPH | Director | 328,743 | $5.54 | $1.82M | $0 | 1 | 2026-06-22 |
| ZYME | Director | 7,500 | $21.95 | $164.6K | $348.8K | 6 | 2024-12-12 |
| SomaLogic, Inc. (SLGCW) Delisted | Executive Chair | 106,930 | $0.09 | $9.2K | $0 | 5 | 2023-03-22 |
| Foundation Medicine, Inc. (FMI) Delisted | Chief Executive Officer | 242,068 | — | — | -$3.33M | 7 | 2018-07-05 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | MPLT | Grant (A) | +7,864 | $0 | EDGAR |
| 2026-06-23 | LAB | Grant (A) | +99,116 | $0 | EDGAR |
| 2026-06-22 | SOPH | Grant (A) | +19,724 | $107.7K | EDGAR |
| 2026-03-02 | LAB | Grant (A) | +57,264 | $67.0K | EDGAR |
| 2025-07-30 | LAB | — | — | $0 | EDGAR |
| 2025-06-24 | LAB | Grant (A) | +94,592 | $0 | EDGAR |
| 2025-03-04 | LAB | Grant (A) | +62,910 | $67.0K | EDGAR |
| 2024-12-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2024-07-02 | LAB | Grant (A) | +43,128 | $0 | EDGAR |
| 2024-01-09 | LAB | Grant (A) | +198,104 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.